J&J Completes Acquisition of Proteologix, Inc.
Johnson & Johnson (J&J) has successfully completed the acquisition of Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated…
Johnson & Johnson (J&J) has successfully completed the acquisition of Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated…